Tags

Type your tag names separated by a space and hit enter

The cost of hospitalization in Crohn's disease.
Am J Gastroenterol. 2000 Feb; 95(2):524-30.AJ

Abstract

OBJECTIVE

The aim of this study was to evaluate the demographics, resource use, and costs associated with hospitalization of Crohn's disease patients.

METHODS

All patients hospitalized at our institution from 7/1/96 to 6/30/97 with a primary diagnosis of "Crohn's Disease" were analyzed using a computerized database. Data are presented "per hospitalization."

RESULTS

A total of 175 hospitalizations (147 patients) were identified. Mean patient age was 36.5 yr; 61% were female; 82% Caucasian. Payer mix was most commonly contracted (57%), commercial (21%), or Medicare (13%). 57% of hospitalizations had a primary surgical procedure; the remainder were medical. Average length of stay was 8.7 days (surgical, 9.6 days; medical, 7.5 days). The average cost of hospitalization, excluding physician fees, was $12,528 (surgical, $14,409; medical, $10,020), whereas average charges were $35,378 (surgical, $46,354; medical, $20,744), including physician fees, which averaged $7,249 (surgical, $11,217; medical, $1,959). Mean reimbursements were $21,968 (surgical, $28,946; medical, $12,666) with average weighted reimbursement rates of 60.17% of hospital charges, 69.57% of physician fees. The distribution of costs across subcategories was: Surgery (39.6%), Pharmacy (18.6%), Laboratory (3.8%), Radiology (2.1%), Pathology (0.8%), Endoscopy (0.3%), and Other Hospital Costs (34.9%). Of the hospitalizations, 87% included treatment with steroids, 23% with immunomodulators, and 14% with aminosalicylates; 27% included the administration of total parenteral nutrition, which accounted for 63% of the total pharmacy costs.

CONCLUSIONS

Surgery accounts for the majority of hospitalizations, nearly 40% of their total costs, and 75% of overall charges and reimbursements. Therapy that decreases the number of surgical hospitalizations should substantially reduce inpatient Crohn's disease costs, as well as overall costs.

Authors+Show Affiliations

University of Chicago, Department of Medicine, Illinois, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

10685762

Citation

Cohen, R D., et al. "The Cost of Hospitalization in Crohn's Disease." The American Journal of Gastroenterology, vol. 95, no. 2, 2000, pp. 524-30.
Cohen RD, Larson LR, Roth JM, et al. The cost of hospitalization in Crohn's disease. Am J Gastroenterol. 2000;95(2):524-30.
Cohen, R. D., Larson, L. R., Roth, J. M., Becker, R. V., & Mummert, L. L. (2000). The cost of hospitalization in Crohn's disease. The American Journal of Gastroenterology, 95(2), 524-30.
Cohen RD, et al. The Cost of Hospitalization in Crohn's Disease. Am J Gastroenterol. 2000;95(2):524-30. PubMed PMID: 10685762.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The cost of hospitalization in Crohn's disease. AU - Cohen,R D, AU - Larson,L R, AU - Roth,J M, AU - Becker,R V, AU - Mummert,L L, PY - 2000/2/24/pubmed PY - 2000/3/11/medline PY - 2000/2/24/entrez SP - 524 EP - 30 JF - The American journal of gastroenterology JO - Am. J. Gastroenterol. VL - 95 IS - 2 N2 - OBJECTIVE: The aim of this study was to evaluate the demographics, resource use, and costs associated with hospitalization of Crohn's disease patients. METHODS: All patients hospitalized at our institution from 7/1/96 to 6/30/97 with a primary diagnosis of "Crohn's Disease" were analyzed using a computerized database. Data are presented "per hospitalization." RESULTS: A total of 175 hospitalizations (147 patients) were identified. Mean patient age was 36.5 yr; 61% were female; 82% Caucasian. Payer mix was most commonly contracted (57%), commercial (21%), or Medicare (13%). 57% of hospitalizations had a primary surgical procedure; the remainder were medical. Average length of stay was 8.7 days (surgical, 9.6 days; medical, 7.5 days). The average cost of hospitalization, excluding physician fees, was $12,528 (surgical, $14,409; medical, $10,020), whereas average charges were $35,378 (surgical, $46,354; medical, $20,744), including physician fees, which averaged $7,249 (surgical, $11,217; medical, $1,959). Mean reimbursements were $21,968 (surgical, $28,946; medical, $12,666) with average weighted reimbursement rates of 60.17% of hospital charges, 69.57% of physician fees. The distribution of costs across subcategories was: Surgery (39.6%), Pharmacy (18.6%), Laboratory (3.8%), Radiology (2.1%), Pathology (0.8%), Endoscopy (0.3%), and Other Hospital Costs (34.9%). Of the hospitalizations, 87% included treatment with steroids, 23% with immunomodulators, and 14% with aminosalicylates; 27% included the administration of total parenteral nutrition, which accounted for 63% of the total pharmacy costs. CONCLUSIONS: Surgery accounts for the majority of hospitalizations, nearly 40% of their total costs, and 75% of overall charges and reimbursements. Therapy that decreases the number of surgical hospitalizations should substantially reduce inpatient Crohn's disease costs, as well as overall costs. SN - 0002-9270 UR - https://www.unboundmedicine.com/medline/citation/10685762/The_cost_of_hospitalization_in_Crohn's_disease_ L2 - http://Insights.ovid.com/pubmed?pmid=10685762 DB - PRIME DP - Unbound Medicine ER -